INVO Fertility, Inc. Liabilities Assumed
INVO Fertility, Inc. (IVF) reported Liabilities Assumed of $167.86 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-06-02.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2026-06-02
- INVO Fertility, Inc. liabilities assumed for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- INVO Fertility, Inc. liabilities assumed for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- INVO Fertility, Inc. liabilities assumed for the quarter ending 2023-12-31 was $106.96K.
- INVO Fertility, Inc. liabilities assumed for the quarter ending 2023-09-30 was $56.31K.
- INVO Fertility, Inc. liabilities assumed for fiscal 2025 was $167.86K, a 11.07% decline from fiscal 2024.
- INVO Fertility, Inc. liabilities assumed for fiscal 2024 was $188.75K, a 61.53% decline from fiscal 2023.
- INVO Fertility, Inc. liabilities assumed for fiscal 2023 was $490.67K, a 445.19% increase from fiscal 2022.
- INVO Fertility, Inc. liabilities assumed for fiscal 2022 was $90.00K.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 6 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|---|
| 2025-12-31 | $167.86K 10-K · filed 2026-06-02 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | $0.00 derived: sum of 2 quarters · filed 2026-06-02 | $188.75K 10-K · filed 2026-06-02 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $188.75K 10-Q · filed 2025-11-17 | ||
| 2024-06-30 | $188.75K 10-Q · filed 2025-08-14 | |||
| 2023-12-31 | $106.96K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-30 | $163.28K derived: sum of 2 quarters · filed 2025-04-30 | $106.97K derived: sum of 3 quarters · filed 2025-04-30 | $490.67K 10-K · filed 2025-04-30 |
| 2023-09-30 | $56.31K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-19 | $10.00 derived: sum of 2 quarters · filed 2024-11-19 | $383.70K 10-Q · filed 2024-11-19 | |
| 2023-06-30 | -$56.30K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2024-11-19 | $327.39K 10-Q/A · filed 2024-11-19 | ||
| 2023-03-31 | $383.69K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $90.00K 10-K/A · filed 2024-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |